Cleveland Clinic Heart, Vascular and Thoracic Institute
Check The Cleveland Clinic Tall Rounds® series:
https://www.vumedi.com/channel/cleveland-clinic/tab/aorta-disease/video/cleveland-clinic-tall-roundsr/
https://www.vumedi.com/channel/cleveland-clinic/tab/aorta-disease/video/cleveland-clinic-tall-roundsr/
- Aorta Disease
- Congenital Heart
- Coronary Artery Disease
- Electrophysiology
- Heart Failure
- Preventive Cardiology
- Valve Disease
- Vascular and Arterial Disease
- Thoracic: Lungs and Esophageal
- Events
Playback speed
10 seconds
ACC 2019 Highlights: TAVR, Electrophysiology, Anti-thrombotic Therapies
23 views
October 29, 2019
A. Michael Lincoff, MD, Director of the Cleveland Clinic Coordinating Center for Clinical Research, reviews ...
read more ↘ the results from clinical trials presented at the 2019 American College of Cardiology Conference focusing on three major practice areas: 1) the use of transcatheter aortic valves (TAVR) in low risk patients (PARTNER 3, Evolut Low) ; 2) electrophysiology studies (Apple Heart, WRAP-IT) ; and 3) anti-thrombotic therapies in patients with atrial fibrillation, acute coronary syndrome or percutaneous intervention (AUGUSTUS, GLASSY). Dr. Lincoff summarizes the studies’ design and results, and provides insight into the potential impact on future care of patients based on these outcomes.
↖ read less
read more ↘ the results from clinical trials presented at the 2019 American College of Cardiology Conference focusing on three major practice areas: 1) the use of transcatheter aortic valves (TAVR) in low risk patients (PARTNER 3, Evolut Low) ; 2) electrophysiology studies (Apple Heart, WRAP-IT) ; and 3) anti-thrombotic therapies in patients with atrial fibrillation, acute coronary syndrome or percutaneous intervention (AUGUSTUS, GLASSY). Dr. Lincoff summarizes the studies’ design and results, and provides insight into the potential impact on future care of patients based on these outcomes.
↖ read less
Comments 0
Login to view comments.
Click here to Login